EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights

Chih-Wei Tung, Siew Chin Chan, Pei-Hsun Cheng, Yi-Ching Chen, Po-Ming Wu, Wei-Chen Lin, Rong-Jane Chen, Bu-Miin Huang, Shang-Hsun Yang iD

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70091 ↗

At a glance

Journal article in Pharmacology Research & Perspectives, 2025. Written by Chih-Wei Tung and 8 co-authors. Institution: Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Major MEDLINE topics: Huntington Disease, Neuroprotective Agents, Deoxyadenosines. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Science and Technology Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Huntington's disease (HD) is a challenging neurodegenerative disorder linked to Huntingtin ( HTT ) gene mutation, lacking an effective cure despite numerous therapeutic attempts. Cordyceps sinensis , recognized for its health benefits, particularly its constituent cordycepin, exhibits neuroprotective effects in various neurodegenerative diseases. However, the neuroprotective potential of cordycepin in HD remains insufficiently explored. In this study, in vitro experiments using HD cell models demonstrate that cordycepin treatment enhances cell survival, slightly diminishes mutant HTT aggregates, and improves neuronal formation. In vivo investigations on R6/2 HD transgenic mice reveal a modest increase in body weight and a slight amelioration in pathological aggregates following cordycepin administration, although behavioral changes are not significant. While the underlying mechanisms remain unexplored, the findings suggest cordycepin's promise as a supplementary therapeutic for HD, providing neuroprotective effects and reducing mutant protein aggregates.

Subjects

MeSH terms (MEDLINE)

Huntington DiseaseNeuroprotective AgentsDeoxyadenosinesAnimalsHuntingtin ProteinMiceMice, TransgenicHumansCell SurvivalDisease Models, AnimalMaleNeuronsProtein Aggregates

Author keywords

CordycepinHuntington's diseaseaggregatemutant huntingtinneuroprotective agent

Substances

cordycepinNeuroprotective AgentsDeoxyadenosinesHuntingtin ProteinHTT protein, humanProtein Aggregates

Authors and institutions

  • Department of Physiology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Food Safety/Hygiene and Risk Management, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

ORCID profiles: Shang-Hsun Yang

Funding

  • National Science and Technology Council

Cite

APA

Tung, C. W., Chan, S. C., Cheng, P. H., Chen, Y. C., Wu, P. M., Lin, W. C., Chen, R. J., Huang, B. M., & Yang, S. H. (2025). Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70091

Vancouver

Tung CW, Chan SC, Cheng PH, Chen YC, Wu PM, Lin WC, et al. Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70091

BibTeX
@article{Tung2025,
  author = {Tung, Chih-Wei and Chan, Siew Chin and Cheng, Pei-Hsun and Chen, Yi-Ching and Wu, Po-Ming and Lin, Wei-Chen and Chen, Rong-Jane and Huang, Bu-Miin and Yang, Shang-Hsun},
  title = {Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70091}
}
Start for free →